Karnofsky performance status and visual analogue scale scores are simple indicators for quality of life in long-term AYA survivors who received allogeneic hematopoietic stem cells transplantation in childhood
- PMID: 36056987
- DOI: 10.1007/s12185-022-03426-5
Karnofsky performance status and visual analogue scale scores are simple indicators for quality of life in long-term AYA survivors who received allogeneic hematopoietic stem cells transplantation in childhood
Abstract
The purpose of this study was to investigate Karnofsky performance status (KPS) scores and visual analogue scale (VAS) scores to explain which domains in the standardized self-reported quality of life (QOL) are instrumental for long-term hematopoietic stem cell transplantation (HSCT) survivors. We conducted a nationwide cross-sectional questionnaire study on 221 survivors with allogeneic-HSCT in 28 pediatric centers. Patient-reported QOL was assessed at a single time point using the 36-item Short-Form Survey (SF-36), the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT), and VAS scores. KPS scores were significantly correlated with both physical and role component summary scores of the SF-36, while the VAS provided by the patient (VASpt) was significantly correlated with the mental component summary score of the SF-36 and many subscales of the FACT-BMT. The VAS provided by the participants' attending physician (VASdoc) was correlated well with KPS scores. A VASpt score more than 40% lower than KPS scores suggested mental health problems. In conclusion, KPS scores might be considered as an indicator for physical and role/social components and VASpt score as an indicator for mental components and HSCT-specific QOL.
Keywords: Allogeneic hematopoietic stem cells transplantation; Karnofsky scores; QOL; Survivors; VAS scores.
© 2022. Japanese Society of Hematology.
Similar articles
-
Impact of chronic GVHD on QOL assessed by visual analogue scale in pediatric HSCT survivors and differences between raters: a cross-sectional observational study in Japan.Int J Hematol. 2022 Jan;115(1):123-128. doi: 10.1007/s12185-021-03227-2. Epub 2021 Oct 3. Int J Hematol. 2022. PMID: 34601694
-
Long-term survivors demonstrate superior quality of life after haploidentical stem cell transplantation to matched sibling donor transplantation.J Transl Med. 2022 Dec 14;20(1):596. doi: 10.1186/s12967-022-03803-y. J Transl Med. 2022. PMID: 36517908 Free PMC article.
-
Quality of Life following Allogeneic Stem Cell Transplantation for Patients Age >60 Years with Acute Myelogenous Leukemia.Biol Blood Marrow Transplant. 2020 Aug;26(8):1527-1533. doi: 10.1016/j.bbmt.2020.04.020. Epub 2020 May 15. Biol Blood Marrow Transplant. 2020. PMID: 32422252
-
Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantation.Semin Hematol. 2012 Jan;49(1):104-9. doi: 10.1053/j.seminhematol.2011.10.004. Semin Hematol. 2012. PMID: 22221790 Review.
-
A Review of Demographic, Medical, and Treatment Variables Associated with Health-Related Quality of Life (HRQOL) in Survivors of Hematopoietic Stem Cell (HSCT) and Bone Marrow Transplantation (BMT) during Childhood.Front Psychol. 2017 Mar 10;8:253. doi: 10.3389/fpsyg.2017.00253. eCollection 2017. Front Psychol. 2017. PMID: 28344563 Free PMC article. Review.
Cited by
-
Impact of multidisciplinary collaborative jejunal nutrition care on nutritional status and quality of life in severely burned patients.Medicine (Baltimore). 2025 Apr 4;104(14):e41965. doi: 10.1097/MD.0000000000041965. Medicine (Baltimore). 2025. PMID: 40193655 Free PMC article.
-
Effect of HER2 expression status on the prognosis of patients with HR+/HER2‑ advanced breast cancer undergoing advanced first‑line endocrine therapy.Oncol Lett. 2023 May 26;26(1):299. doi: 10.3892/ol.2023.13885. eCollection 2023 Jul. Oncol Lett. 2023. PMID: 37323815 Free PMC article.
-
Incorporating patient-reported outcome data into a predictive calculator for allogeneic hematopoietic cell transplantation recipients.Cancer. 2024 May 15;130(10):1826-1835. doi: 10.1002/cncr.35189. Epub 2024 Jan 10. Cancer. 2024. PMID: 38198511 Free PMC article.
References
-
- Japanese Data Center for Hematopoietic Cell Transplantation JDCfHC. Hematopoietic Cell Transplantation in Japan. Annual Report of Nationwide Survey 2019. The Japanese Data Center for Hematopoietic Cell Transplantation/ The Japan Society for Hematopoietic Cell Transplantation. http://www.jdchct.or.jp/data/report/2019/ . Accessed 29 Aug 2022
-
- Chow EJ, Anderson L, Baker KS, Bhatia S, Guilcher GM, Huang JT, et al. Late effects surveillance recommendations among survivors of childhood hematopoietic cell transplantation: a children’s oncology group report. Biol Blood Marrow Transplant. 2016;22(5):782–95. https://doi.org/10.1016/j.bbmt.2016.01.023 . - DOI - PubMed - PMC
-
- Tanzi EM. Health-related quality of life of hematopoietic stem cell transplant childhood survivors: state of the science. J Pediatr Oncol Nurs. 2011;28(4):191–202. https://doi.org/10.1177/1043454211408100 . - DOI - PubMed
-
- Ishida Y. Quality of life after hematopoietic stem cell transplantation in childhood (In Japanese). J Hematop Cell Transplantat. 2019;8(4):107–21. - DOI
-
- Sato A, Ishida Y, Oshiro R, Nakajima S, Inoue M, Hayakawa A et al. Comparison of quality of life after allogeneic stem cell transplantation performed during childhood and adolescents and young adults generation: a nationwide study in Japan (in submission). Bone Marrow Transplant 2022.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources